These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9145028)

  • 1. Development and standardization of an immuno-quantified solid phase assay for HIV-1 aspartyl protease activity and its application to the evaluation of inhibitors.
    Fournout S; Roquet F; Salhi SL; Seyer R; Valverde V; Masson JM; Jouin P; Pau B; Nicolas M; Hanin V
    Anal Chem; 1997 May; 69(9):1746-52. PubMed ID: 9145028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunoenzymatic solid-phase assay for quantitative determination of HIV-1 protease activity.
    Gutiérrez OA; Salas E; Hernández Y; Lissi EA; Castrillo G; Reyes O; Garay H; Aguilar A; García B; Otero A; Chavez MA; Duarte CA
    Anal Biochem; 2002 Aug; 307(1):18-24. PubMed ID: 12137774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of HIV-1 protease activity by use of crude preparations of enzyme and biotinylated substrate.
    Yu SL; Wang N; Liou CY; Syu WJ
    J Virol Methods; 1995 May; 53(1):63-73. PubMed ID: 7635927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective and facile assay of human immunodeficiency virus protease activity by a novel fluorogenic reaction.
    Yu Z; Kabashima T; Tang C; Shibata T; Kitazato K; Kobayashi N; Lee MK; Kai M
    Anal Biochem; 2010 Feb; 397(2):197-201. PubMed ID: 19852926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of inhibition of HIV-1 protease activity by an enzyme-linked immunosorbent assay (ELISA).
    Mansfeld HW; Schulz S; Grütz G; von Baehr R; Ansorge S
    J Immunol Methods; 1993 May; 161(2):151-5. PubMed ID: 8505545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automation of a high-performance liquid chromatography-based enzyme assay: evaluation of inhibition constants for human immunodeficiency virus-1 protease inhibitors.
    Pazhanisamy S; Stuver CM; Livingston DJ
    Anal Biochem; 1995 Jul; 229(1):48-53. PubMed ID: 8533894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights from atomic-resolution X-ray structures of chemically synthesized HIV-1 protease in complex with inhibitors.
    Johnson EC; Malito E; Shen Y; Pentelute B; Rich D; Florián J; Tang WJ; Kent SB
    J Mol Biol; 2007 Oct; 373(3):573-86. PubMed ID: 17869270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a monoclonal antibody produced in an attempt to mimic the active site of HIV aspartyl protease using haptens based on inhibitor models.
    Hanin V; Campagne JM; Dominice C; Mani JC; Dufour MN; Jouin P; Pau B
    J Immunol Methods; 1994 Aug; 173(2):139-47. PubMed ID: 8046248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties.
    Frecer V; Berti F; Benedetti F; Miertus S
    J Mol Graph Model; 2008 Oct; 27(3):376-87. PubMed ID: 18678515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipid prodrug inhibitors of the HIV protease. Antiviral activity and pharmacokinetics in rats.
    Hostetler KY; Richman DD; Forssen EA; Selk L; Basava R; Gardner MF; Parker S; Basava C
    Biochem Pharmacol; 1994 Oct; 48(7):1399-404. PubMed ID: 7945439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity.
    Tucker TJ; Lumma WC; Payne LS; Wai JM; de Solms SJ; Giuliani EA; Darke PL; Heimbach JC; Zugay JA; Schleif WA
    J Med Chem; 1992 Jul; 35(14):2525-33. PubMed ID: 1635054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A solid phase assay for the protease of human immunodeficiency virus.
    Wondrak EM; Copeland TD; Louis JM; Oroszlan S
    Anal Biochem; 1990 Jul; 188(1):82-5. PubMed ID: 2221372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted design.
    Thompson WJ; Fitzgerald PM; Holloway MK; Emini EA; Darke PL; McKeever BM; Schleif WA; Quintero JC; Zugay JA; Tucker TJ
    J Med Chem; 1992 May; 35(10):1685-701. PubMed ID: 1588551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 protease inhibitors containing statine: inhibitory potency and antiviral activity.
    Fehrentz JA; Chomier B; Bignon E; Venaud S; Chermann JC; Nisato D
    Biochem Biophys Res Commun; 1992 Oct; 188(2):865-72. PubMed ID: 1445327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide aldehydes as inhibitors of HIV protease.
    Sarubbi E; Seneci PF; Angelastro MR; Peet NP; Denaro M; Islam K
    FEBS Lett; 1993 Mar; 319(3):253-6. PubMed ID: 8458418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure.
    Marastoni M; Bazzaro M; Salvadori S; Bortolotti F; Tomatis R
    Bioorg Med Chem; 2001 Apr; 9(4):939-45. PubMed ID: 11354677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains.
    Tamamura H; Koh Y; Ueda S; Sasaki Y; Yamasaki T; Aoki M; Maeda K; Watai Y; Arikuni H; Otaka A; Mitsuya H; Fujii N
    J Med Chem; 2003 Apr; 46(9):1764-8. PubMed ID: 12699395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could angiotensin I be produced from a renin substrate by the HIV-1 protease?
    Sharma SK; Evans DB; Hui JO; Heinrikson RL
    Anal Biochem; 1991 Nov; 198(2):363-7. PubMed ID: 1799223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
    Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
    Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.